United States — National Institutes of Health & Canada

United States — National Institutes of Health: The United States — National Institutes of Health>>>'s decision to end funding for global infectious disease research networks has drawn criticism amid ongoing outbreaks.

Canada: Canada>>> is monitoring several individuals exposed to hantavirus, with one confirmed case, and has implemented temporary travel measures, indicating a proactive but cautious approach to public health.

United States — National Institutes of Health: The United States — National Institutes of Health primarily funded the study on blood biomarkers, demonstrating its support for medical research.

Canada: Canada was one of the locations where the study on the new brain imaging test (MK6240) was conducted, contributing to the research findings.

United States — National Institutes of Health: The United States — National Institutes of Health is a co-owner of one of the newly issued US patents, indicating its collaboration with Medicenna Therapeutics on IL-4 Superkine fusion proteins.

Canada: Canada is another jurisdiction where Medicenna Therapeutics received a patent grant for its IL-2 Super Agonist and checkpoint inhibitors for cancer treatment, further strengthening its global patent portfolio.

United States — National Institutes of Health: The United States — National Institutes of Health provided a nearly $4.5 million grant to Rendever to study ways to reduce social isolation among seniors.